Brief: CSL Notes Announcement By United States Administration On 2 April
07/04/2026 03:10
April 7 (Reuters) - CSL Ltd CSL.AX: NOTES ANNOUNCEMENT BY UNITED STATES ADMINISTRATION ON 2 APRIL INITIAL VIEW IS THAT MOST OF CSL'S U.S. PRODUCT SALES WILL NOT BE SUBJECT TO TARIFFS U.S. ADMINISTRATION HAS RECOGNISED UNIQUE NATURE OF PLASMA-DERIVED THERAPIES UNDER PROCLAMATION EFFECTIVE DATE FOR ANY TARIFF IMPACTS IS 29 SEPTEMBER 2026 Further company coverage: CSL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Csl
See all newsEU Commission opens antitrust probe into Sanofi's flu vaccine campaign (updated)
EU Commission opens antitrust probe into Sanofi's flu vaccine campaign
Analysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
US military requires flu vaccine for some after outbreak in Texas training center
Corrected: BUZZ-Australian healthcare stocks hit a six-week high, acting as a primary hedge on ASX